← Open Payments lookup

DAN STEINFINK: Open Payments

NPI 1144295296 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,158 in 53 payments from 15 companies in 2025. Trend: 2023 $1,556 · 2024 $1,708 · 2025 $1,158

Food & beverage: $1,130Education: $27
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$162
Otsuka America Pharmaceutical, Inc.9$153
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$148
E.R. Squibb & Sons, L.L.C.6$115
ABBVIE INC.4$110
Takeda Pharmaceuticals U.S.A., Inc.6$109
Lundbeck LLC3$62
Corium, LLC2$61
Eisai Inc.2$59
Axsome Therapeutics, Inc.2$43

Products named: REXULTI, INGREZZA, CAPLYTA, COBENFY, VRAYLAR, TRINTELLIX, Azstarys, Leqembi.

Industry payments across TX — which companies pay providers there.